Keytruda has been a gold mine for Merck—but the cancer drug’s patent is running out, and the company has struck out on many prospective new uses
is about to run out for Merck & Co. Keytruda, one of the world’s top-selling drugs, powered its maker for the past decade. The therapy’s annual sales neared $21 billion last year, about a third of Merck’s revenue.
Yet a drop in sales looms afterDeutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
U.S. Stopped Ukraine Striking Moscow on Anniversary: ReportAs the first anniversary of Russia’s invasion of Ukraine approached in February, Kyiv prepared to attack Moscow—only for the plans to be postponed at the request of the U.S., according to a report.
Weiterlesen »
Canada finance minister urges striking workers to accept 'very fair' govt offerCanada's Finance Minister Chrystia Freeland on Monday urged striking public sector workers to accept what she called a 'very fair' government proposal, even as the workers' union warned it would ramp up pressure to get its demands met.
Weiterlesen »
Sierra Snowpack: Satellite Images Show Striking Difference Between Spring 2022 and 2023Satellite images of the Sierra Nevada show a striking difference between the 2022 and 2023 spring snowpacks.
Weiterlesen »
East Bay carjacking suspect arrested after striking, injuring construction worker on 1-80One man was arrested and another seriously injured Tuesday morning as authorities chased a carjacking suspect on Interstate 80 from Contra Costa County through Solano County.
Weiterlesen »
Why Mark Robinson’s far-right gubernatorial campaign mattersBy any fair measure, the North Carolina candidate is among the most hateful radicals to seek statewide office in the United States in recent memory. (via MaddowBlog)
Weiterlesen »